HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
2011

HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo

Sample size: 37 publication Evidence: high

Author Information

Author(s): Satou Yorifumi, Yasunaga Jun-ichirou, Zhao Tiejun, Yoshida Mika, Miyazato Paola, Takai Ken, Shimizu Kei, Ohshima Koichi, Green Patrick L., Ohkura Naganari, Yamaguchi Tomoyuki, Ono Masahiro, Sakaguchi Shimon, Matsuoka Masao

Primary Institution: Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan

Hypothesis

Transgenic expression of HBZ in CD4+ T cells induces T-cell lymphomas and systemic inflammation.

Conclusion

The study shows that HBZ expression in CD4+ T cells is a key mechanism of HTLV-1-induced neoplastic and inflammatory diseases.

Supporting Evidence

  • HBZ transgenic mice developed skin lesions and T-cell lymphomas.
  • Transgenic expression of HBZ increased Foxp3+ Treg cells but impaired their function.
  • HBZ interacts with Foxp3 and NFAT, disrupting Treg cell function.

Takeaway

This study found that a virus can make certain immune cells grow too much and not work properly, which can lead to cancer and inflammation.

Methodology

Transgenic mice expressing the HBZ gene were analyzed for T-cell proliferation and lymphoma development.

Limitations

The study primarily uses a mouse model, which may not fully replicate human disease.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.ppat.1001274

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication